Celia J. A. Morgan

10.3k total citations
122 papers, 6.6k citations indexed

About

Celia J. A. Morgan is a scholar working on Pharmacology, Cognitive Neuroscience and Biological Psychiatry. According to data from OpenAlex, Celia J. A. Morgan has authored 122 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pharmacology, 40 papers in Cognitive Neuroscience and 28 papers in Biological Psychiatry. Recurrent topics in Celia J. A. Morgan's work include Cannabis and Cannabinoid Research (42 papers), Treatment of Major Depression (36 papers) and Tryptophan and brain disorders (28 papers). Celia J. A. Morgan is often cited by papers focused on Cannabis and Cannabinoid Research (42 papers), Treatment of Major Depression (36 papers) and Tryptophan and brain disorders (28 papers). Celia J. A. Morgan collaborates with scholars based in United Kingdom, United States and Australia. Celia J. A. Morgan's co-authors include Valerie H. Curran, H. Valerie Curran, Tom P. Freeman, Gráinne Schäfer, Chandni Hindocha, Sunjeev K. Kamboj, Brigitta Brandner, Ravi Das, Will Lawn and Michael Bloomfield and has published in prestigious journals such as Nature reviews. Neuroscience, The Journal of Immunology and Scientific Reports.

In The Last Decade

Celia J. A. Morgan

118 papers receiving 6.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celia J. A. Morgan United Kingdom 45 4.4k 2.2k 1.6k 1.3k 1.3k 122 6.6k
Valerie H. Curran United Kingdom 45 4.1k 0.9× 2.7k 1.3× 2.5k 1.6× 2.4k 1.9× 931 0.7× 141 9.2k
Gabriella Gobbi Canada 48 2.6k 0.6× 3.3k 1.5× 1.3k 0.9× 1.4k 1.1× 911 0.7× 138 7.7k
H. Valerie Curran United Kingdom 38 2.2k 0.5× 1.4k 0.6× 1.2k 0.8× 884 0.7× 415 0.3× 94 4.0k
Sagnik Bhattacharyya United Kingdom 52 5.7k 1.3× 2.9k 1.3× 2.4k 1.5× 1.5k 1.2× 394 0.3× 173 8.7k
Carl L. Hart United States 45 2.2k 0.5× 2.2k 1.0× 1.3k 0.8× 1.2k 0.9× 304 0.2× 100 5.4k
Anne Lingford‐Hughes United Kingdom 45 2.0k 0.5× 2.9k 1.3× 1.6k 1.0× 1.1k 0.8× 328 0.3× 184 7.4k
Bernard Le Foll Canada 58 4.5k 1.0× 5.3k 2.4× 1.5k 1.0× 1.3k 1.0× 320 0.3× 328 11.6k
Nadia Solowij Australia 41 5.1k 1.2× 2.5k 1.2× 2.0k 1.3× 1.1k 0.8× 192 0.2× 111 7.3k
Jorge Manzanares Spain 52 5.5k 1.2× 4.5k 2.1× 1.2k 0.8× 486 0.4× 608 0.5× 223 8.5k
Mehmet Sofuoglu United States 49 1.2k 0.3× 3.0k 1.4× 846 0.5× 883 0.7× 366 0.3× 204 7.6k

Countries citing papers authored by Celia J. A. Morgan

Since Specialization
Citations

This map shows the geographic impact of Celia J. A. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia J. A. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia J. A. Morgan more than expected).

Fields of papers citing papers by Celia J. A. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celia J. A. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia J. A. Morgan. The network helps show where Celia J. A. Morgan may publish in the future.

Co-authorship network of co-authors of Celia J. A. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Celia J. A. Morgan. A scholar is included among the top collaborators of Celia J. A. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celia J. A. Morgan. Celia J. A. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Petrilli, Kat, Lindsey A. Hines, Sally Adams, et al.. (2023). High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence. Addictive Behaviors. 144. 107740–107740. 15 indexed citations
3.
Hindocha, Chandni, Gianluca Baio, Rachel Lees, et al.. (2023). Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational Psychiatry. 13(1). 131–131. 14 indexed citations
4.
Mollaahmetoğlu, Özden Merve, Edward Palmer, Emily L. Maschauer, et al.. (2021). The acute effects of alcohol on state rumination in the laboratory. Psychopharmacology. 238(6). 1671–1686. 8 indexed citations
5.
Walsh, Zach, Özden Merve Mollaahmetoğlu, Johanna Louise Keeler, et al.. (2021). Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. BJPsych Open. 8(1). e19–e19. 82 indexed citations
6.
Mollaahmetoğlu, Özden Merve, et al.. (2021). A randomised, double‐blind study investigating the relationship between early childhood trauma and the rewarding effects of morphine. Addiction Biology. 26(6). e13047–e13047. 14 indexed citations
7.
Grabski, Meryem, Anna Borissova, Beth Marsh, Celia J. A. Morgan, & Valerie H. Curran. (2020). Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review. Behavioural Brain Research. 392. 112629–112629. 34 indexed citations
8.
Stevens, Tobias, et al.. (2019). Greater empathy in MDMA users. Journal of Psychopharmacology. 33(3). 295–304. 14 indexed citations
9.
Stevens, Tobias, et al.. (2019). Impaired empathy and increased anger following social exclusion in non-intoxicated opioid users. Psychopharmacology. 237(2). 419–430. 13 indexed citations
10.
Bitto, Alessandro, Herman Tung, Kejun Ying, et al.. (2019). AGING AND MITOCHONDRIAL DISEASE: SHARED MECHANISMS AND THERAPIES?. Innovation in Aging. 3(Supplement_1). S395–S395.
11.
Curran, Valerie H., et al.. (2018). Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?. Psychological Medicine. 49(9). 1574–1580. 39 indexed citations
12.
Morgan, Celia J. A., et al.. (2018). Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Translational Psychiatry. 8(1). 181–181. 99 indexed citations
13.
Hindocha, Chandni, Tom P. Freeman, Meryem Grabski, et al.. (2018). Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction. 113(9). 1696–1705. 83 indexed citations
14.
Lawn, Will, Jaime E. C. Hallak, José Alexandre S. Crippa, et al.. (2017). Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey. Scientific Reports. 7(1). 15201–15201. 55 indexed citations
15.
16.
Lawn, Will, Tom P. Freeman, Chandni Hindocha, et al.. (2015). The effects of nicotine dependence and acute abstinence on the processing of drug and non-drug rewards. Psychopharmacology. 232(14). 2503–2517. 20 indexed citations
17.
Carhart‐Harris, Robin, Matthew B. Wall, David Erritzøe, et al.. (2013). The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. The International Journal of Neuropsychopharmacology. 17(4). 527–540. 78 indexed citations
18.
Morgan, Celia J. A., et al.. (2009). Is Semantic Processing Impaired in Individuals With High Schizotypy?. The Journal of Nervous and Mental Disease. 197(4). 232–238. 13 indexed citations
19.
20.
Morgan, Celia J. A., Ali Mofeez, Brigitta Brandner, Lesley Bromley, & H. Valerie Curran. (2003). Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose?response study. Psychopharmacology. -1(1). 1–1. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie H. Curran Breakdown of academic impact, for papers by Gabriella Gobbi Breakdown of academic impact, for papers by H. Valerie Curran Breakdown of academic impact, for papers by Sagnik Bhattacharyya Breakdown of academic impact, for papers by Carl L. Hart Breakdown of academic impact, for papers by Anne Lingford‐Hughes Breakdown of academic impact, for papers by Bernard Le Foll Breakdown of academic impact, for papers by Nadia Solowij Breakdown of academic impact, for papers by Jorge Manzanares Breakdown of academic impact, for papers by Mehmet Sofuoglu
Rankless by CCL
2026